INSP Form 4 reports disposition transactions

Herbert Timothy P. reported disposition transactions in a Form 4 filing for INSP.

Accepted by SEC EDGAR 02/11/2026 - 05:20 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Herbert Timothy P. reported disposition transactions in a Form 4 filing for INSP. The filing lists transactions totaling 968 shares at a weighted average price of $66.33 per share. Following the reported transactions, holdings were 34,321 shares.

Insider Trade Summary

Exercise Price or Tax Liability: 968 shares

Exercise Price or Tax Liability 1 txn

Insider Herbert Timothy P.

Role CEO and President

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	968	$66.33	$64K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 34,321 shares (Direct); Common Stock — 63,658 shares (Indirect, By Trust)

Footnotes (3)

1. F1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.
2. F2. Includes (i) 113 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2025 and (ii) 27 shares acquired under the Plan on December 31, 2025.
3. F3. Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did INSP CEO Timothy P. Herbert report on February 9, 2026?

Timothy P. Herbert reported a tax-related share disposition on February 9, 2026. The company withheld 968 shares of Inspire Medical Systems common stock at $66.33 per share to satisfy taxes from a vesting performance stock unit award, rather than an open-market sale.

How many Inspire Medical Systems (INSP) shares does Timothy P. Herbert hold after this Form 4?

After the reported transaction, Timothy P. Herbert beneficially owned 34,321 Inspire Medical Systems common shares directly. He also held 63,658 additional shares indirectly through the Timothy P. Herbert 2018 Family Continuation Trust c/u the 2018 Grantor Retained Annuity Trust.

Was the February 2026 INSP insider transaction an open-market sale?

The February 2026 transaction was not an open-market sale. It was a tax-withholding disposition where 968 shares were retained by the issuer to cover tax obligations triggered by vesting of a performance stock unit award granted to Timothy P. Herbert.

What does transaction code F mean in the INSP Form 4 for Timothy P. Herbert?

Transaction code F indicates shares used to pay a tax liability or exercise price. In this case, 968 Inspire Medical Systems shares were withheld to satisfy taxes due upon vesting of a performance stock unit award granted to CEO and President Timothy P. Herbert.

How are Timothy P. Herbert’s indirect INSP shareholdings structured?

Timothy P. Herbert’s indirect holdings total 63,658 Inspire Medical Systems shares. These are held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust, as disclosed in the Form 4 explanatory footnotes.

Does the INSP Form 4 indicate participation in an employee stock purchase plan?

Yes. The Form 4 notes that Herbert’s reported holdings include 113 shares acquired under the 2018 Employee Stock Purchase Plan on June 30, 2025 and 27 shares acquired under the same plan on December 31, 2025, increasing his beneficial ownership position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Herbert Timothy P.

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MN 55416

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		F		968(1)	D	$66.33	34,321(2)	D
Common Stock								63,658	I	By Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.

2. Includes (i) 113 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2025 and (ii) 27 shares acquired under the Plan on December 31, 2025.

3. Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.

	/s/ Bryan Phillips, Attorney-in-Fact for Timothy P. Herbert	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.